Site Search

​​​​​​​Biological medicines, such as proteins and nucleic acids, can be much more efficient than traditional synthetic drugs. However, getting them to where they are needed in the body is a big challenge. IMI’s COMPACT project developed prototypes of new drug delivery systems ...

​​​​​​​Today’s paradigms of bringing innovation to patients are challenged by new developments, such as a growing patient demand for timely access to promising therapies. To address this, more adaptive drug pathways are needed and the ADAPT-SMART project set out to address that ...